Cargando…
Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Society for Endocrinology
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255566/ https://www.ncbi.nlm.nih.gov/pubmed/22232542 http://dx.doi.org/10.1530/ERC-11-0287 |
| _version_ | 1782221022243586048 |
|---|---|
| author | Koumarianou, Anna Antoniou, Stavroula Kanakis, George Economopoulos, Nikolaos Rontogianni, Dimitra Ntavatzikos, Anastasios Tsavaris, Nikolaos Pectasides, Dimitrios Dimitriadis, George Kaltsas, Gregory |
| author_facet | Koumarianou, Anna Antoniou, Stavroula Kanakis, George Economopoulos, Nikolaos Rontogianni, Dimitra Ntavatzikos, Anastasios Tsavaris, Nikolaos Pectasides, Dimitrios Dimitriadis, George Kaltsas, Gregory |
| author_sort | Koumarianou, Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3255566 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Society for Endocrinology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32555662012-02-01 Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours Koumarianou, Anna Antoniou, Stavroula Kanakis, George Economopoulos, Nikolaos Rontogianni, Dimitra Ntavatzikos, Anastasios Tsavaris, Nikolaos Pectasides, Dimitrios Dimitriadis, George Kaltsas, Gregory Endocr Relat Cancer Letter to the Editor Society for Endocrinology 2012-02 /pmc/articles/PMC3255566/ /pubmed/22232542 http://dx.doi.org/10.1530/ERC-11-0287 Text en © 2012 Society for Endocrinology http://www.endocrinology.org/journals/reuselicence/ This is an Open Access article distributed under the terms of the Society for Endocrinology's Re-use Licence (http://www.endocrinology.org/journals/reuselicence/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Koumarianou, Anna Antoniou, Stavroula Kanakis, George Economopoulos, Nikolaos Rontogianni, Dimitra Ntavatzikos, Anastasios Tsavaris, Nikolaos Pectasides, Dimitrios Dimitriadis, George Kaltsas, Gregory Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours |
| title | Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours |
| title_full | Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours |
| title_fullStr | Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours |
| title_full_unstemmed | Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours |
| title_short | Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours |
| title_sort | combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255566/ https://www.ncbi.nlm.nih.gov/pubmed/22232542 http://dx.doi.org/10.1530/ERC-11-0287 |
| work_keys_str_mv | AT koumarianouanna combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT antonioustavroula combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT kanakisgeorge combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT economopoulosnikolaos combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT rontogiannidimitra combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT ntavatzikosanastasios combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT tsavarisnikolaos combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT pectasidesdimitrios combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT dimitriadisgeorge combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours AT kaltsasgregory combinationtreatmentwithmetronomictemozolomidebevacizumabandlongactingoctreotideformalignantneuroendocrinetumours |